Published in Mol Cancer Res on November 06, 2012
CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest. Sci Rep (2014) 0.84
Systematically labeling developmental stage-specific genes for the study of pancreatic β-cell differentiation from human embryonic stem cells. Cell Res (2014) 0.83
Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display. Mol Cell Proteomics (2013) 0.79
Expression Analyses Revealed Thymic Stromal Co-Transporter/Slc46A2 Is in Stem Cell Populations and Is a Putative Tumor Suppressor. Mol Cells (2015) 0.77
SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance. Oncogenesis (2016) 0.75
RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients. Tumour Biol (2015) 0.75
Acute Simian Varicella Virus Infection Causes Robust and Sustained Changes in Gene Expression in the Sensory Ganglia. J Virol (2016) 0.75
Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells. Oncogene (2014) 0.75
Mechanism of immune evasion in breast cancer. Onco Targets Ther (2017) 0.75
Epigenetic Profiling of H3K4Me3 Reveals Herbal Medicine Jinfukang-Induced Epigenetic Alteration Is Involved in Anti-Lung Cancer Activity. Evid Based Complement Alternat Med (2016) 0.75
Reduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancer. Oncol Lett (2015) 0.75
Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma. Cancer Cell Int (2016) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science (2005) 23.44
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods (1995) 16.00
Trastuzumab--mechanism of action and use in clinical practice. N Engl J Med (2007) 12.73
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res (1992) 9.02
Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol (2007) 8.16
A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics (2005) 7.13
HER-2 testing in breast cancer using parallel tissue-based methods. JAMA (2004) 4.60
Galectins. Structure and function of a large family of animal lectins. J Biol Chem (1994) 4.29
Apoptosis of T cells mediated by galectin-1. Nature (1995) 3.54
HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin Breast Cancer (2004) 3.50
Galectin-1: a small protein with major functions. Glycobiology (2006) 3.06
The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer (Auckl) (2010) 2.57
Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res (1991) 2.45
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A (2006) 2.26
Proximity ligation assays: a recent addition to the proteomics toolbox. Expert Rev Proteomics (2010) 1.70
Galectin-1 as a potential cancer target. Br J Cancer (2005) 1.45
Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res (1999) 1.44
Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Res (2009) 1.42
Galectins: a new family of regulators of inflammation. Clin Immunol (2000) 1.31
Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins. Proc Natl Acad Sci U S A (2003) 1.22
High expression of a cytokeratin-associated protein in many cancers. Proc Natl Acad Sci U S A (2006) 1.08
Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation. Glycoconj J (1995) 1.07
Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett (2009) 1.04
Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene. Bioconjug Chem (2010) 1.02
A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease. BMC Cancer (2012) 1.00
Isolation of a novel mouse gene, mSVS-1/SUSD2, reversing tumorigenic phenotypes of cancer cells in vitro. Cancer Sci (2007) 0.99
Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells. Cancer Res (2003) 0.98
Regulatory T cells and breast cancer: implications for immunopathogenesis. Cancer Metastasis Rev (2010) 0.97
The flow cytometric PKH-26 assay for the determination of T-cell mediated cytotoxic activity. Methods (2003) 0.88
T cell tolerance to tumors and cancer immunotherapy. Adv Exp Med Biol (2007) 0.85
Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. Proc Natl Acad Sci U S A (2006) 1.37
Interspecies signaling between Veillonella atypica and Streptococcus gordonii requires the transcription factor CcpA. J Bacteriol (2009) 0.82
Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers. S D Med (2010) 0.81
Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens. Cancer Prev Res (Phila) (2014) 0.78
Status of HER-2 gene amplification in breast cancers from Native American women. Cancer Genet Cytogenet (2008) 0.75